Horinaka, Kio

Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy

Kashiwakura, Y., Nakajima, Y., Horinaka, K., Lopes, T. J. S., Furuta, Y., Yamaguchi, Y., Baatartsogt, N., Hayakawa, M., Katakai, Y., Uchiyama, S., et al. (2026) · Blood

Hemophilia Treatment and ResearchVirus-based gene therapy research

Cited by 3

Engineering a compact high-fidelity Staphylococcus aureus Cas9 variant with broader targeting range and mechanistic insights into its activation

Omura, S. N., Nakagawa, R., Kajimoto, S., Okazaki, S., Ishiguro, S., Mori, H., Onishi, K., Kashiwakura, Y., Hiramoto, T., Horinaka, K., et al. (2026) · Nature Communications

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 2